A Year of SGLT2 Inhibitors in Veterinary Medicine

Webinar and On Demand

Webinar Overview

The ACVIM is pleased to invite ACVIM Diplomates, ACVIM Candidates, and specialty technicians to the new ACVIM Product Spotlight Webinar: A Year of SGLT2 inhibitors in Veterinary Medicine.

Webinar Description

SGLT2 inhibitors reduce hyperglycemia by increasing glucose excretion into the urine. This class of drugs are commonly used for the management of human type 2 diabetes mellitus. Two SGLT2 inhibitors have now been approved for the treatment of feline diabetes mellitus. Widespread use of these drugs over the last year has increased our knowledge and experience with their use in cats.

This lecture will review the mechanism of action, results of field studies, and current literature on the use of SGLT2 inhibitors in cats. The efficacy and adverse events reported in the pivotal field studies will be compared and contrasted to those reported in clinical veterinary medicine since drug approval. The lecture will also review recommendations for case selection, monitoring and management of adverse effects based on clinical experience in the last year

Learning Objectives

Upon completion, the participant will gain insight into the mechanism of action of SGLT2 inhibitors in feline diabetes mellitus
Upon completion, participants will be able to identify, treat and understand common adverse events associated with SGLT2i use in feline diabetes mellitus
Upon completion, participants will be able to formulate potential uses for SGLT2i in feline medicine and consider potential future applications of SGLT2i in veterinary medicine

Registration

Registration for the on-demand webinar is now open.

Existing Users

Registration for the webinar is open! Register below.

New Users

Registration for the webinar is open! Register below.

Create Account to Register

Speakers

Jocelyn Mott

Jocelyn Mott, DVM, DACVIM (SAIM), FACVIM (feline and canine diabetes)

Jocelyn Mott, DVM, DACVIM (SAIM), FACVIM (feline and canine diabetes)
Associate Professor, University of Florida

Dr. Mott graduated from Western College of Veterinary Medicine in Saskatoon, SK, Canada. After graduation, she completed an internship at Oklahoma State University and a small animal internal medicine residency at the University of Wisconsin-Madison. Dr. Mott is board certified by the ACVIM in small animal internal medicine and fellow accredited by ACVIM in feline and canine diabetes. Dr. Mott is currently an associate professor of small animal internal medicine at the University of Florida.

Catharine Scott-Moncrieff

MA, Vet MB, MRCVS, DECVIM, DSAM, DACVIM (SAIM)

Catharine Scott-Moncrieff, MA, Vet MB, MRCVS, DECVIM, DSAM, DACVIM (SAIM)
Professor, Purdue University

Dr. Scott-Moncrieff received her Veterinary Degree from the University of Cambridge in 1985. She completed an internship in small animal medicine and surgery at the University of Saskatchewan, Canada, and a residency and Master of Science degree in internal medicine at Purdue University. In 1989 she joined the faculty of Purdue University, where she is currently a Professor of small animal internal medicine and head of the Department of Veterinary Clinical Sciences. She is a Diplomate of the American College of Veterinary Internal Medicine (small animal), and the European College of Veterinary Internal Medicine (companion animal). Her research and clinical interests are canine and feline endocrinology.

Webinar Information

Date: On Demand
Location: On Demand
Audience: ACVIM Diplomates and Candidates, ECVIM-CA Diplomates and Candidates, specialty technicians, and nonmembers
Specialty: SAIM
Type: Webinar

RACE Application Status

CE credit is not offered for the on-demand webinar.

For additional questions, please contact us at Learning@ACVIM.org.